Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 698 | 1,011 | 2,164 | 6,258 | 10,205 |
| TOTAL | $829 | $1,258 | $2,719 | $6,491 | $10,588 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 0 | 3 | 23 |
| Intangibles | 353 | 509 | 666 | 823 | 980 |
| TOTAL | $353 | $509 | $666 | $826 | $1,003 |
| Total Assets | $1,182 | $1,767 | $3,385 | $7,317 | $11,591 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 249 | 254 | 124 | 88 | 233 |
| TOTAL | $304 | $261 | $282 | $100 | $294 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,946 | 1,000 | 0 | 193 | 473 |
| TOTAL | $1,000 | $1,000 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,304 | $1,261 | $282 | $100 | $294 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41 | 41 | 41 | 41 | 41 |
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Retained earnings | -189,619 | -188,956 | -186,185 | -182,018 | -178,097 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 193 |
| TOTAL | $-122 | $506 | $3,103 | $7,217 | $11,297 |
| Total Liabilities And Equity | $1,182 | $1,767 | $3,385 | $7,317 | $11,591 |